2017
DOI: 10.1007/s00259-017-3790-5
|View full text |Cite
|
Sign up to set email alerts
|

18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage

Abstract: The present findings support the role of FDG PET as a robust progression biomarker even in a naturalist population of MCI-AD. However, not the AD-typical diagnostic-pattern in posterior regions but the middle and inferior temporal metabolism captures speed of conversion to dementia in MCI-AD since baseline. The highlighted prognostic pattern is a further, independent source of heterogeneity in MCI-AD and affects a primary-endpoint on interventional clinical trials (time of conversion to dementia).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
27
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 32 publications
(28 citation statements)
references
References 42 publications
1
27
0
Order By: Relevance
“…[23][24][25] Preserved metabolism in PCC was hereby confirmed, but we demonstrated that this finding is significantly dependent on the severity of cognitive impairment. 28,29 Previous studies in smaller groups suggested that FDG PET might be able to mirror clinical heterogeneity of DLB by showing core feature metabolic correlates, but firm conclusions on the interplay between core features and potentially confounding clinical and demographic variables, such as MMSE score, age, and education, were unfeasible. 26,27 Instead, the relatively preserved metabolism in bilateral MTL was less affected by the severity of cognitive impairment, was not affected by the region used as reference for intensity normalization, and thus may retain diagnosis utility at all stages.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[23][24][25] Preserved metabolism in PCC was hereby confirmed, but we demonstrated that this finding is significantly dependent on the severity of cognitive impairment. 28,29 Previous studies in smaller groups suggested that FDG PET might be able to mirror clinical heterogeneity of DLB by showing core feature metabolic correlates, but firm conclusions on the interplay between core features and potentially confounding clinical and demographic variables, such as MMSE score, age, and education, were unfeasible. 26,27 Instead, the relatively preserved metabolism in bilateral MTL was less affected by the severity of cognitive impairment, was not affected by the region used as reference for intensity normalization, and thus may retain diagnosis utility at all stages.…”
Section: Discussionmentioning
confidence: 99%
“…FDG PET, as a general marker of neurodegeneration, may help in understanding the neurodegeneration processes leading to either one. 28,29 Previous studies in smaller groups suggested that FDG PET might be able to mirror clinical heterogeneity of DLB by showing core feature metabolic correlates, but firm conclusions on the interplay between core features and potentially confounding clinical and demographic variables, such as MMSE score, age, and education, were unfeasible. [30][31][32] Despite the relatively high number of patients, we could not directly compare subgroups according to individual core feature because "pure" subgrouping was hampered by the very low number of patients presenting only 1 core feature, as is the common clinical presentation of DLB.…”
Section: Discussionmentioning
confidence: 99%
“…Metabolic connectivity is a valuable concept in the fast‐developing field of brain connectivity, which less dependent on neurovascular coupling as in fMRI and are indicative of a presumed steady state of neuronal activity during the recording interval . Growing evidence indicates that metabolic connectivity may serve a marker of normal and pathological cognitive function . So far, many analysis models of metabolic connectivity are best established in neurodegenerative disorders, such as seed correlation or IRCA, PCA and independent components analysis, sparse inverse covariance estimation, and graph theory .…”
Section: Discussionmentioning
confidence: 95%
“…24,25 Growing evidence indicates that metabolic connectivity may serve a marker of normal and pathological cognitive function. [26][27][28] So far, many analysis models of metabolic connectivity are best established in neurodegenerative disorders, such as seed correlation or IRCA, PCA and independent components analysis, sparse inverse covariance estimation, and graph theory. 24 Here, we first adopted a covariance method to construct metabolic networks such as VBM or cortical thickness covariance networks and then used graph theory to parse them.…”
Section: Brain Metabolism and Metabolic Brain Covariance Networkmentioning
confidence: 99%
“…As for ITG, significant hypometabolism is seen during early AD, despite minimal amyloid beta deposition (La Joie, et al, 2012; Scheff, et al, 2011). Hypometabolism in the ITG has been reported to be associated with conversion from MCI to AD (Convit, et al, 2000; Morbelli, et al, 2017). This region is involved in verbal fluency and its increased activity predicts better cognitive reserve in AD patients (Halawa, et al, 2019; Weissberger, et al, 2017).…”
Section: Discussionmentioning
confidence: 99%